Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Fysioterapien.dk Gladsaxe ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   8.9% 11.0% 7.2% 4.4% 9.5% 8.2% 13.9% 13.6%   Credit score (0-100)   29 23 34 46 25 29 16 17   Credit rating   BB BB BBB BBB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,411 1,082 1,099 687 908 889 0.0 0.0   EBITDA   596 226 694 48.2 -289 120 0.0 0.0   EBIT   596 226 694 48.2 -289 120 0.0 0.0   Pre-tax profit (PTP)   590.6 219.8 684.8 37.3 -292.4 140.3 0.0 0.0   Net earnings   459.4 170.0 532.3 8.7 -232.6 106.2 0.0 0.0   Pre-tax profit without non-rec. items   591 220 685 37.3 -292 140 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   597 307 839 848 615 721 641 641   Interest-bearing liabilities   1.5 1.5 1.5 0.0 54.4 1.8 0.0 0.0   Balance sheet total (assets)   847 500 1,193 929 783 1,020 641 641   Net Debt   -137 -57.8 -439 -85.2 -19.4 -99.8 -641 -641     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,411 1,082 1,099 687 908 889 0.0 0.0   Gross profit growth   72.6% -23.3% 1.6% -37.5% 32.1% -2.0% -100.0% 0.0%   Employees   3 2 1 1 1 1 0 0   Employee growth %   200.0% -33.3% -50.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   847 500 1,193 929 783 1,020 641 641   Balance sheet change%   -31.6% -41.0% 138.6% -22.1% -15.7% 30.2% -37.1% 0.0%   Added value   595.9 226.4 693.9 48.2 -289.2 120.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   42.2% 20.9% 63.1% 7.0% -31.9% 13.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   57.2% 33.6% 82.0% 6.1% -33.3% 16.3% 0.0% 0.0%   ROI %   72.9% 50.0% 120.8% 7.7% -37.6% 21.1% 0.0% 0.0%   ROE %   56.2% 37.6% 92.9% 1.0% -31.8% 15.9% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   70.4% 61.3% 70.3% 91.2% 78.5% 70.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -23.0% -25.5% -63.3% -176.9% 6.7% -83.0% 0.0% 0.0%   Gearing %   0.2% 0.5% 0.2% 0.0% 8.8% 0.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   731.2% 445.6% 622.6% 3,790.6% 26.8% 23.5% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.6 1.6 3.7 9.5 4.7 3.4 0.0 0.0   Current Ratio   1.6 1.6 3.7 9.5 4.7 3.4 0.0 0.0   Cash and cash equivalent   138.6 59.3 440.8 85.2 73.8 101.6 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   156.3 88.5 529.5 554.8 615.0 722.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   199 113 694 48 -289 120 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   199 113 694 48 -289 120 0 0   EBIT / employee   199 113 694 48 -289 120 0 0   Net earnings / employee   153 85 532 9 -233 106 0 0